The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Holtmann et al., N Engl J Med 354(8):832-840 February 23, 2006.

Correction
PreviousPrevious
Volume 355:429 July 27, 2006 Number 4
NextNext

A Placebo-Controlled Trial of Itopride in Functional Dyspepsia

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Holtmann, G.
A Placebo-Controlled Trial of Itopride in Functional Dyspepsia . On page 832, lines 2 and 3 of the Background section of the Abstract should have read, "itopride, a dopamine D2 antagonist with anti-acetylcholinesterase effects," rather than "with acetylcholinesterase effects," as printed.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.